Sponsor Pipeline

Shanghai Tongji Hospital, Tongji University School of Medicine Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
7
Active Trials
3
Recruiting
4
Disease Areas
Active Trials by Phase
Phase 1/2
1
Phase 1
1
Early Phase 1
4
Not specified
1
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT06987916 Efficacy and Safety Evaluation of U01(ssCART-19) in B-Cell Lymphoma B Cell Lymphoma Recruiting
Phase 1
NCT07043218 A Clinical Study Exploring Universal CAR-T Cell in Patients With Relapsed/Refractory… B-cell Acute Lymphoblastic Leukemia Not Yet Recruiting
Early Phase 1
NCT06375161 Anti-CD19-CAR-T Cells in Relapsed/Refractory B-cell Tumor Patients. B Cell Malignancies Recruiting
NCT06519344 An Exploratory Clinical Study Evaluating the Safety and Efficacy of Intravenous… B Cell Malignancies Not Yet Recruiting
NCT06951425 An Exploratory Clinical Study of the Efficiency and Safety of TH027 in the Treatment of… Solid Tumors Not Yet Recruiting
NCT07384390 TH-CAR-027 for Grade 4 Gliomas R/R Grade 4 Glioma Not Yet Recruiting
Not specified
NCT07064109 Multi-omics Characterization and Model Construction of Colchicine Anti-inflammatory… ACS - Acute Coronary Syndrome Recruiting
Disease Areas
Get alerts when Shanghai Tongji Hospital, Tongji University School of Medicine's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free